您的位置:PharmaNews 行业信息 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

USIBC Salutes Abbott Laboratories for 100 Years of Improving Healthcare in India

WASHINGTON--(BUSINESS WIRE)--Jul 30, 2010 - Today the U.S.-India Business Council (USIBC) saluted Abbott Laboratories for 100 years of improving healthcare in India. In 1910, Abbott was one of the first multinationals to establish operations in India. Over the past century, Abbott has been dedicated to connecting Indian patients with access to quality medication and patient care, enhancing the quality of life for its customers.

USIBC President Ron Somers praised Abbott's dedication to India, noting, “Abbott has never wavered in their belief in India. With the recent purchase of Piramal's Healthcare Solutions Business, it's clear that the first 100 years are just the beginning.” Mr. Somers went on to note that Abbott has been feted with recent accolades of "Best Pharma Company of the Year 2010" and "Best Pharma OTC Company of the Year 2010" by Pharmaleaders.

According to Mr. Somers, “Turning science into caring is not just a phrase for Abbott India. Through their various patient outreach initiatives, educational programs and access programs, Abbott is helping lead the way for a new era of U.S.-India healthcare collaboration which has the potential to improve millions of lives.” He noted that with President Barack Obama set to visit India in November, “Abbott's India operations embody the best example of collaboration and modern innovation that we hope the two governments will recognize and continue to foster.”

In line with a key focus of USIBC's Coalition for Healthy India, Abbott has committed to increase diabetes awareness in India. The disease currently affects the working age population and is the leading cause of blindness, kidney failure, heart attack, stroke and amputation. Abbott's targeted initiatives, including their free education drives and blood glucose testing, have created awareness among India's patient population. These types of initiatives have not gone unnoticed. Today, USIBC applauds Abbott's efforts to address the issue of India being the number one country in the world to suffer with the highest rate of diabetes, and looks forward to Abbot's continuing contribution in this important field, looking toward a committed 100 years to come.

The U.S.-India Business Council, formed in 1975 at the request of the Government of India and the U.S. Government to advance commercial ties between the world's two largest free-market democracies, is hosted under the aegis of the U.S. Chamber of Commerce. The U.S. Chamber of Commerce is the world's largest business federation representing more than 3 million businesses and organizations of every size, sector, and region. For more information please visit www.usibc.com.

www.usibc.com

Contact: U.S.-India Business Council (USIBC)
Kathryn Van Dyken, 202-463-5768
kvandyken@uschamber.com

 

转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  Charles River Announces Mutual Terminati

  Conatus Pharmaceuticals Acquires Pfizer'

  Federal Jury Finds Cornell University's

  Employment at NJ Biotechnology Companies

  Devax Receives CE Mark for the AXXESS Dr

  WILEX AG recommends shareholders not to

  VaxGen and diaDexus Complete Merger

  WuXi PharmaTech Well Positioned to Conti

药明康德出售搁浅 作价过高或成祸首

全球制药业R&D投入更趋理性

黑龙江研制中药壳聚糖复合药膜 可加速顽固性

重磅!抗生素政策再度收紧,集采下所剩不多

原研药与仿制药之争激烈,近40亿品种市场迎

本土中药CRO企业与跨国药企“牵手”,推动中

生物制剂集采真的来了!

中药配方颗粒站在了发展风口上,这类企业将

中药配方颗粒,将被纳入网售禁止清单!

广东60种高血压糖尿病等药品平均降价近半

相关评论

    
本文章所属分类:首页 行业信息